Skip to main content



05-03-2021 | Rheumatology | News | Article

High rates of long-term glucocorticoid use in people with GCA, PMR

Real-world study results suggest that less than a third of patients with giant cell arteritis and/or polymyalgia rheumatica are able to discontinue glucocorticoid treatment for at least 6 months, and a substantial proportion remain on prednisone for at least 2 years.

04-03-2021 | Rheumatology | News | Article

Telephone CBT for insomnia possible option for patients with osteoarthritis

Cognitive behavioral therapy for insomnia could be delivered via the telephone to patients with osteoarthritis, proving useful for those unable to access in-person options, OATS trial findings suggest.

03-03-2021 | Rheumatology | News | Article

Secondary CVD prevention ‘should be priority’ after myocardial infarction in RA patients

Following myocardial infarction, people with rheumatoid arthritis have an elevated long-term risk for mortality and further cardiovascular disease events, researchers report.

02-03-2021 | Rheumatology | News | Article

Fibromyalgia-related pain not improved with vitamin D supplementation

Twelve weeks of high-dose vitamin D supplementation does not improve pain levels for women with fibromyalgia, research suggests.

01-03-2021 | Rheumatology | News | Article

Study highlights risk for disordered eating in adolescents with chronic musculoskeletal pain

Researchers have found that adolescents with chronic musculoskeletal pain, particularly those with gastrointestinal problems, may be at risk for disordered eating.

25-02-2021 | Rheumatology | News | Article

PsA linked to heightened risk for type 2 diabetes

People with psoriatic arthritis may have an elevated risk for type 2 diabetes that is mediated in part by BMI, researchers report.

24-02-2021 | Rheumatology | News | Article

Rheumatologists have ‘crucial role’ in increasing COVID-19 vaccine uptake

Two studies have evaluated the perspectives of people with rheumatic and musculoskeletal diseases on COVID-19 vaccination, with both finding that a physician’s recommendation would improve patients’ willingness to be vaccinated.

23-02-2021 | Rheumatology | News | Article

Real-world data show tocilizumab effectiveness for GCA

Real-world data confirm the effectiveness of tocilizumab for decreasing relapse risk and allowing corticosteroid reduction in heavily treated patients with giant cell arteritis.

22-02-2021 | Rheumatology | News | Article

No benefit of apremilast for patients with ankylosing spondylitis

The phase 3 POSTURE trial has demonstrated no clinical benefit of apremilast for patients with active ankylosing spondylitis and no prior exposure to biologic agents.

19-02-2021 | Rheumatology | News | Article

Treatment response unaffected by diagnosis age in older people with RA

Older people with late-onset rheumatoid arthritis show a similar response to biologic or targeted synthetic DMARDs to their peers whose disease onset was earlier in life, Japanese study findings indicate.

18-02-2021 | Rheumatology | News | Article

START trial shows no benefit of high-intensity strength training for knee osteoarthritis

High-intensity strength training does not significantly reduce pain or knee joint compressive forces among people with knee osteoarthritis, suggest findings from the START trial.

17-02-2021 | Rheumatology | News | Article

Combining ultrasound with other triage tools may aid PsA diagnosis

Using musculoskeletal ultrasound alongside other triage modalities may improve the detection of psoriatic arthritis among patients with psoriasis and musculoskeletal symptoms, researchers report.

16-02-2021 | Rheumatology | News | Article

ILD ‘not uncommon’ in real-world RA patients

Interstitial lung disease is present in nearly 5% of patients with rheumatoid arthritis and can increase the risk for death, report researchers.

15-02-2021 | Rheumatology | News | Article

Support for biomarker studies to guide interleukin inhibitor use in COVID-19

IL-1 inhibition is associated with a significant reduction in overall mortality risk among hospitalized patients with COVID-19 and hyperinflammation, while patients with markedly elevated C-reactive protein or low lactate dehydrogenase may benefit from IL-6 inhibition, researchers report.

12-02-2021 | Rheumatology | News | Article

ACR releases clinical guidance on COVID-19 vaccination

The American College of Rheumatology has issued clinical guidance recommending COVID-19 vaccination for people with rheumatic and musculoskeletal diseases.

11-02-2021 | Rheumatology | News | Article

Long-term data confirm risk to joints with tanezumab

medwireNews: Long-term treatment with tanezumab is associated with an increased risk for joint-related adverse events in patients with hip or knee osteoarthritis and moderate-to-severe pain despite prior stable use of NSAIDs, phase 3 study data show.

10-02-2021 | Rheumatology | News | Article

EULAR issues ‘points to consider’ on immunomodulatory treatment for COVID-19

EULAR has issued guidance on the pathophysiology of COVID-19 and the potential use of immunomodulatory therapies for its treatment.

09-02-2021 | Rheumatology | News | Article

Better foot health management needed for RA patients

The majority of patients with rheumatoid arthritis do not receive appropriate foot care, UK research suggests.

08-02-2021 | Rheumatology | News | Article

Multiple autoantibody positivity linked to increased radiographic progression in early RA

Individuals with a wide range of anti-modified protein antibodies experience higher rates of early radiographic progression than those with just a single antibody type, show data from the Scottish Early Rheumatoid Arthritis inception cohort.

05-02-2021 | Rheumatology | News | Article

FDA issues safety alert on risk for CV events, cancer with tofacitinib

Click through for more information on this Drug Safety Communication

Image Credits